WallStreetZenWallStreetZen

NASDAQ: LEXX
Lexaria Bioscience Corp Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their LEXX stock forecasts and price targets.

Forecast return on equity

Is LEXX forecast to generate an efficient return?
Company
-104.69%
Industry
15.79%
Market
14%
LEXX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is LEXX forecast to generate an efficient return on assets?
Company
-107.26%
Industry
0.95%
LEXX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

LEXX revenue growth forecast

How is LEXX forecast to perform vs Biotechnology companies and vs the US market?
Company
268.5%
Industry
188.63%
Market
16.77%
LEXX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
LEXX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

LEXX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
LEXX$0.76N/AN/A
TMBR$1.49N/AN/A
AMPE$0.29N/AN/A
INM$1.28N/AN/A
SPRC$0.62N/AN/A

Lexaria Bioscience Stock Forecast FAQ

What is LEXX's forecast return on equity (ROE) for 2023-2024?

(NASDAQ: LEXX) forecast ROE is -104.69%, which is considered weak.

If you're new to stock investing, here's how to buy Lexaria Bioscience stock.

What is LEXX's forecast return on assets (ROA) for 2023-2024?

(NASDAQ: LEXX) forecast ROA is -107.26%, which is lower than the forecast US Biotechnology industry average of 0.95%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.